RecallDepth
Class II Ongoing

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

This recall is currently active, issued November 13, 2024. It was issued by Baxter Healthcare Corporation.

Company
Baxter Healthcare Corporation
Recall Initiated
October 30, 2024
Posted
November 13, 2024
Recall Number
D-0039-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
60,594 units
Firm Location
Deerfield, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Missing Label

Distribution

Nationwide within the USA

Lot / Code Info

Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025

More recalls by Baxter Healthcare Corporation

View all recalls by this company →

Other recent Class II Drug recalls